Stockscreener 앱 받기
2.56
9.40%
0.22
시간 외 거래:
2.56
전일 마감가:
$2.34
열려 있는:
$2.3
하루 거래량:
2.95M
Relative Volume:
2.99
시가총액:
$229.07M
수익:
$34.48M
순이익/손실:
$-102.07M
주가수익비율:
-1.4066
EPS:
-1.82
순현금흐름:
$-104.90M
1주 성능:
+32.64%
1개월 성능:
+36.90%
6개월 성능:
-32.10%
1년 성능:
-38.76%
1일 변동 폭
$2.295
$2.58
1주일 범위
$1.865
$2.58
52주 변동 폭
$1.50
$8.33
Caribou Biosciences Inc Stock (CRBU) Company Profile
명칭
Caribou Biosciences Inc
전화
510-982-6030
주소
2929 7TH STREET, SUITE 105, BERKELEY
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-11 | 개시 | Truist | Buy |
| 2022-02-18 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-11-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-08-17 | 개시 | BofA Securities | Buy |
| 2021-08-17 | 개시 | Citigroup | Neutral |
| 2021-08-17 | 개시 | SVB Leerink | Outperform |
모두보기
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Shares Bounce 25% But Its Business Still Trails The Industry - Simply Wall St
Vanguard Group Inc's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com
Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock? - Insider Monkey
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by Exchange Traded Concepts LLC - Defense World
STATE STREET CORP's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com
Following a 49% decline over last year, recent gains may please Caribou Biosciences, Inc. (NASDAQ:CRBU) institutional owners - Simply Wall St
Its Stock Has Paid Off Big Time For Caribou Biosciences Inc - SETE News
How to interpret Caribou Biosciences Inc (CRBU)’s stock chart patterns - US Post News
Daily Market Movement: Caribou Biosciences Inc (CRBU) Sees a 5.56 Increase, Closing at 1.90 - The Dwinnex
Dimensional Fund Advisors LP Has $4.30 Million Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat
A better buy-in window may exist right now for Caribou Biosciences Inc (CRBU) - SETE News
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Purchased by Green Alpha Advisors LLC - Defense World
Caribou Biosciences Inc (CRBU) presents a great opportunity, but the stock is slightly undervalued - US Post News
Analyzing Ratios: Caribou Biosciences Inc (CRBU)’s Financial Story Unveiled - The Dwinnex
Susquehanna Fundamental Investments LLC Sells 91,637 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Acquired by American Century Companies Inc. - Defense World
Point72 DIFC Ltd Purchases 23,995 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Point72 Asset Management L.P. Decreases Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat
Point72 Asset Management L.P. Sells 1,241,478 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
1,482,900 Shares in Caribou Biosciences, Inc. (NASDAQ:CRBU) Bought by Renaissance Technologies LLC - Defense World
31,831 Shares in Caribou Biosciences, Inc. (NASDAQ:CRBU) Purchased by Point72 Asia Singapore Pte. Ltd. - Defense World
Taking on analysts’ expectations and winning: Caribou Biosciences Inc (CRBU) - SETE News
Daily Market Movement: Caribou Biosciences Inc (CRBU) Sees a 2.06 Increase, Closing at 1.98 - The Dwinnex
Caribou Biosciences Inc (CRBU) presents a great opportunity, but the stock is slightly overvalued - US Post News
Caribou Biosciences: CB-010, chRDNA Technology Continue To Show Promise In Gene Editing - Seeking Alpha
Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Acquired by Point72 DIFC Ltd - Defense World
Wall Street SWOT: Caribou Biosciences stockInnovative biotech with HLA-matching focus - Investing.com
CRISPR and CRISPR-Associated (Cas) Genes Market 2024 Business Standards and Competition Landscape 2032 – Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics – Cauverynews - Cauverynews
Stocks of Caribou Biosciences Inc (CRBU) are poised to climb above their peers - SETE News
CRBUCaribou Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024 - StockTitan
Bank of New York Mellon Corp Buys 38,098 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
How Analyst Ratings Affect Caribou Biosciences Inc Inc. (CRBU) Price Performance - The InvestChronicle
Metric Deep Dive: Understanding Caribou Biosciences Inc (CRBU) Through its Ratios - The Dwinnex
Are Caribou Biosciences Inc’shares a good deal? - US Post News
A closer look at Caribou Biosciences Inc (CRBU) is warranted - US Post News
Upward Trajectory: Caribou Biosciences Inc (CRBU) Posts a Gaine, Closing at 2.10 - The Dwinnex
With 60% ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) boasts of strong institutional backing - Yahoo Finance
7 Top Gene-Editing Stocks to Buy | Investing - U.S News & World Report Money
Take off with Caribou Biosciences Inc (CRBU): Get ready for trading - SETE News
Check Out Caribou Biosciences Inc (CRBU)’s Trade Data Rather Than the Analysts’ Views - SETE News
Candriam S.C.A. Has $1.03 Million Stake in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat
Candriam S.C.A. Sells 520,000 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Should investors be concerned about Caribou Biosciences Inc (CRBU)? - US Post News
Global Genetic Engineering Market Size To Worth USD 8.95 Billion By 2033 | CAGR Of 20.82% - GlobeNewswire Inc.
Vir Biotechnology Appoints Jason O’Byrne as Chief Financial Officer - StockTitan
Balance Sheet Breakdown: Caribou Biosciences Inc (CRBU)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Caribou Biosciences, Inc. Announces Resignation of Jason O?Byrne as Chief Financial Officer, Effective September 27, 2024 - Marketscreener.com
Here's Why We're Watching Caribou Biosciences' (NASDAQ:CRBU) Cash Burn Situation - Simply Wall St
Check out these key findings about Caribou Biosciences Inc (CRBU) - SETE News
Caribou Biosciences Inc (CRBU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):